| 1 | beta | 7,730 |
| 2 | beta-2 | 476 |
| 3 | cyclooxygenase | 443 |
| 4 | cyclooxygenase-2 | 433 |
| 5 | calcium-channel | 215 |
| 6 | angiotensin-receptor | 179 |
| 7 | beta2 | 135 |
| 8 | β2 | 134 |
| 9 | cyclo-oxygenase | 133 |
| 10 | alpha-1 | 105 |
| 11 | alpha-2 | 81 |
| 12 | catechol-o-methyltransferase | 76 |
| 13 | beta-1 | 72 |
| 14 | alpha2 | 67 |
| 15 | cyclo-oxygenase-2 | 57 |
| 16 | phosphatidylinositol-3-kinase | 50 |
| 17 | at1-receptor | 48 |
| 18 | beta2-adrenoceptor | 44 |
| 19 | beta-adrenoreceptor | 43 |
| 20 | β-2 | 25 |
| 21 | gα | 20 |
| 22 | sphingosine-1-phosphate | 20 |
| 23 | alpha1-adrenergic | 19 |
| 24 | beta-3 | 19 |
| 25 | alpha-receptor | 18 |
| 26 | co-stimulation | 18 |
| 27 | renin-angiotensin-aldosterone-system | 18 |
| 28 | β2-adrenoceptor | 16 |
| 29 | renin-angiotensin-system | 15 |
| 30 | β-receptor | 14 |
| 31 | ha3ar | 13 |
| 32 | β₂ | 12 |
| 33 | atv+r | 9 |
| 34 | ss2 | 9 |
| 35 | beta1-receptor | 8 |
| 36 | at-1 | 7 |
| 37 | calcium-entry | 7 |
| 38 | sodium-channel | 7 |
| 39 | α-adrenoceptor | 7 |
| 40 | β-peptide | 7 |
| 41 | β1-adrenoceptor | 7 |
| 42 | β₂-adrenoceptor | 7 |
| 43 | cycloxygenase | 6 |
| 44 | glyceryltrinitrate | 6 |
| 45 | mineralocorticoid-receptor | 6 |
| 46 | nomac/e | 6 |
| 47 | p-jak | 6 |
| 48 | potassium-channel | 6 |
| 49 | β-protein | 6 |
| 50 | β2-adrenoreceptor | 6 |
| 51 | alpha1-receptor | 5 |
| 52 | amidohydrolase | 5 |
| 53 | beta-peptide | 5 |
| 54 | beta1+2 | 5 |
| 55 | beta₂ | 5 |
| 56 | video-electroencephalography | 5 |
| 57 | β1-receptor | 5 |
| 58 | 4,6-diamidino-2-phenylindole | 4 |
| 59 | angiotensin-ii-receptor | 4 |
| 60 | arndt | 4 |
| 61 | beta-adrenergic-receptor | 4 |
| 62 | beta-protein | 4 |
| 63 | cyclooxygenase- | 4 |
| 64 | doxycyclin | 4 |
| 65 | elastase-alpha | 4 |
| 66 | factory-made | 4 |
| 67 | low-titre | 4 |
| 68 | meo-m-bdc | 4 |
| 69 | non-beta | 4 |
| 70 | positively-charged | 4 |
| 71 | psyllogel | 4 |
| 72 | rfrp-3-immunoreactive | 4 |
| 73 | si/sio | 4 |
| 74 | topoisomerase-i | 4 |
| 75 | univent | 4 |
| 76 | β1-selective | 4 |
| 77 | 10×109 | 3 |
| 78 | 52466 | 3 |
| 79 | 79.95 | 3 |
| 80 | at-1r | 3 |
| 81 | at-2 | 3 |
| 82 | beta1-adrenoreceptor | 3 |
| 83 | catechol-o-methyl-transferase | 3 |
| 84 | cb1-receptor | 3 |
| 85 | cg-b | 3 |
| 86 | diethylaminoethyl | 3 |
| 87 | dishevelled | 3 |
| 88 | dreb2 | 3 |
| 89 | eta/etb | 3 |
| 90 | gp2b/3a | 3 |
| 91 | gpiibiiia | 3 |
| 92 | hkv1.5 | 3 |
| 93 | multiple-pathway | 3 |
| 94 | non-n-methyl-d-aspartate | 3 |
| 95 | non-substrate | 3 |
| 96 | p-component | 3 |
| 97 | pan-selectin | 3 |
| 98 | pesticide-oligo | 3 |
| 99 | ptmba | 3 |
| 100 | sp-receptor | 3 |
| 101 | tetraphenylethene | 3 |
| 102 | tgase | 3 |
| 103 | trp-channel | 3 |
| 104 | α1-ars | 3 |
| 105 | β1-adrenoreceptor | 3 |
| 106 | 2,3-dihydroquinazolin-4 | 2 |
| 107 | 21/164 | 2 |
| 108 | 3-hydroxyquinolin | 2 |
| 109 | a-ldl | 2 |
| 110 | alfa-1 | 2 |
| 111 | alk5/smads | 2 |
| 112 | amkr | 2 |
| 113 | angular-type | 2 |
| 114 | antagonist-precipitated | 2 |
| 115 | anti-β | 2 |
| 116 | atp-grasp | 2 |
| 117 | benzene-1,3,5-tri-carboxyl-ate | 2 |
| 118 | beta₂-adrenergic | 2 |
| 119 | bkca-channel | 2 |
| 120 | ca2+-channel | 2 |
| 121 | calcium-channels | 2 |
| 122 | diestradiol | 2 |
| 123 | dl-threo-methylphenidate | 2 |
| 124 | erbb-family | 2 |
| 125 | fibrinolysin | 2 |
| 126 | gauducheau | 2 |
| 127 | gi-coupled | 2 |
| 128 | hemoximeter | 2 |
| 129 | hostility-in | 2 |
| 130 | immune-derived | 2 |
| 131 | inhibitors/receptor | 2 |
| 132 | jadera | 2 |
| 133 | munc-18b | 2 |
| 134 | muscarinic-receptor | 2 |
| 135 | m₃ | 2 |
| 136 | nonmyxopapillary | 2 |
| 137 | phosphodiesterase-type-5 | 2 |
| 138 | ribokinase | 2 |
| 139 | sbn | 2 |
| 140 | short-echo | 2 |
| 141 | v-5 | 2 |
| 142 | -592a | 1 |
| 143 | -cycloalkyls | 1 |
| 144 | 1-blocker-induced | 1 |
| 145 | 1/th | 1 |
| 146 | 2,352 | 1 |
| 147 | 215.8-268.9 | 1 |
| 148 | 241/576 | 1 |
| 149 | 3.16-fold | 1 |
| 150 | 5-alpha-receptor | 1 |
| 151 | 5-arylidene-3- | 1 |
| 152 | 9831 | 1 |
| 153 | =1,3-di- | 1 |
| 154 | =rotheca | 1 |
| 155 | a-sympathetic | 1 |
| 156 | adrenergic-receptor | 1 |
| 157 | allel | 1 |
| 158 | alpha-2c | 1 |
| 159 | alpha1-adrenoreceptor | 1 |
| 160 | antagonists/inverse | 1 |
| 161 | anticholinergic/beta | 1 |
| 162 | arb/calcium-channel | 1 |
| 163 | arg389arg-beta1 | 1 |
| 164 | atp-k+-channel | 1 |
| 165 | benzodiazepine-positive | 1 |
| 166 | beta-1,2 | 1 |
| 167 | beta-2-adrenoceptor | 1 |
| 168 | beta-2-receptor | 1 |
| 169 | beta/proposed | 1 |
| 170 | betareceptor | 1 |
| 171 | bk-channel | 1 |
| 172 | cannabinoid1 | 1 |
| 173 | cb-receptor | 1 |
| 174 | ccb-ras | 1 |
| 175 | chlerodendrum | 1 |
| 176 | chromane | 1 |
| 177 | codon39 | 1 |
| 178 | constitutive1 | 1 |
| 179 | cuts/10 | 1 |
| 180 | d-aspartate-receptor | 1 |
| 181 | desmethylprodine | 1 |
| 182 | dichloroaniline | 1 |
| 183 | diuretics/beta | 1 |
| 184 | diuretics/β | 1 |
| 185 | dl-threo-3-hydroxyaspartate | 1 |
| 186 | drugs-or | 1 |
| 187 | dualaction | 1 |
| 188 | electuary | 1 |
| 189 | estradiol/norgestrel | 1 |
| 190 | gabarα1 | 1 |
| 191 | glp-1-receptor | 1 |
| 192 | gtn/24 | 1 |
| 193 | hcn-specific | 1 |
| 194 | ics+laba+long-acting | 1 |
| 195 | if-channel | 1 |
| 196 | inhibitors/angiotensin-receptor | 1 |
| 197 | kcnk | 1 |
| 198 | kcnk3/kcnk9/kcnk18 | 1 |
| 199 | l-channel | 1 |
| 200 | m1/m4 | 1 |
| 201 | mbaa | 1 |
| 202 | medroxyprogesterone-acetate | 1 |
| 203 | metylenedioxymethamphetamine | 1 |
| 204 | micro-1 | 1 |
| 205 | mixed-action | 1 |
| 206 | mrna+ | 1 |
| 207 | mrna-expressing | 1 |
| 208 | niacin/lrpt | 1 |
| 209 | non-alpha-2 | 1 |
| 210 | non-mu | 1 |
| 211 | nonproblematic | 1 |
| 212 | norethisterone-enanthate | 1 |
| 213 | ofprecipitated | 1 |
| 214 | oral-delivery-system | 1 |
| 215 | overexpression-transgenic | 1 |
| 216 | p-componen | 1 |
| 217 | pancreatic-g-protein-coupled | 1 |
| 218 | pca-administered | 1 |
| 219 | peripheral-expressing | 1 |
| 220 | phophodiesterase-4-selective | 1 |
| 221 | pingchan | 1 |
| 222 | poly-4 | 1 |
| 223 | post-tnf | 1 |
| 224 | postneuromuscular | 1 |
| 225 | pregnancy-specific-beta | 1 |
| 226 | quinolone-fused | 1 |
| 227 | r-methamphetamine | 1 |
| 228 | receptor-alpha-chain | 1 |
| 229 | rotheca | 1 |
| 230 | rs3916874 | 1 |
| 231 | self-reduce | 1 |
| 232 | serotonin2 | 1 |
| 233 | serotonin2-receptor | 1 |
| 234 | single-pathway | 1 |
| 235 | slb-induced | 1 |
| 236 | spectrum-beta | 1 |
| 237 | thc-containing | 1 |
| 238 | theophylline-beta | 1 |
| 239 | vaccine.in | 1 |
| 240 | vaporrub | 1 |
| 241 | wintry | 1 |
| 242 | wt/deletion | 1 |
| 243 | µ-agonistic | 1 |
| 244 | ß-2 | 1 |
| 245 | ß-receptor | 1 |
| 246 | ß2 | 1 |
| 247 | α/β-adrenoreceptor | 1 |
| 248 | α4β | 1 |
| 249 | β-1.3/1.6-d-glucan | 1 |
| 250 | β-predominant | 1 |
| 251 | β25-35 | 1 |
| 252 | μ-type | 1 |
| 253 | τhat | 1 |
| 1 | -592a | 1 |
| 2 | -cycloalkyls | 1 |
| 3 | 1-blocker-induced | 1 |
| 4 | 1/th | 1 |
| 5 | 10×109 | 3 |
| 6 | 2,3-dihydroquinazolin-4 | 2 |
| 7 | 2,352 | 1 |
| 8 | 21/164 | 2 |
| 9 | 215.8-268.9 | 1 |
| 10 | 241/576 | 1 |
| 11 | 3-hydroxyquinolin | 2 |
| 12 | 3.16-fold | 1 |
| 13 | 4,6-diamidino-2-phenylindole | 4 |
| 14 | 5-alpha-receptor | 1 |
| 15 | 5-arylidene-3- | 1 |
| 16 | 52466 | 3 |
| 17 | 79.95 | 3 |
| 18 | 9831 | 1 |
| 19 | =1,3-di- | 1 |
| 20 | =rotheca | 1 |
| 21 | a-ldl | 2 |
| 22 | a-sympathetic | 1 |
| 23 | adrenergic-receptor | 1 |
| 24 | alfa-1 | 2 |
| 25 | alk5/smads | 2 |
| 26 | allel | 1 |
| 27 | alpha-1 | 105 |
| 28 | alpha-2 | 81 |
| 29 | alpha-2c | 1 |
| 30 | alpha-receptor | 18 |
| 31 | alpha1-adrenergic | 19 |
| 32 | alpha1-adrenoreceptor | 1 |
| 33 | alpha1-receptor | 5 |
| 34 | alpha2 | 67 |
| 35 | amidohydrolase | 5 |
| 36 | amkr | 2 |
| 37 | angiotensin-ii-receptor | 4 |
| 38 | angiotensin-receptor | 179 |
| 39 | angular-type | 2 |
| 40 | antagonist-precipitated | 2 |
| 41 | antagonists/inverse | 1 |
| 42 | anti-β | 2 |
| 43 | anticholinergic/beta | 1 |
| 44 | arb/calcium-channel | 1 |
| 45 | arg389arg-beta1 | 1 |
| 46 | arndt | 4 |
| 47 | at-1 | 7 |
| 48 | at-1r | 3 |
| 49 | at-2 | 3 |
| 50 | at1-receptor | 48 |
| 51 | atp-grasp | 2 |
| 52 | atp-k+-channel | 1 |
| 53 | atv+r | 9 |
| 54 | benzene-1,3,5-tri-carboxyl-ate | 2 |
| 55 | benzodiazepine-positive | 1 |
| 56 | beta | 7,730 |
| 57 | beta-1 | 72 |
| 58 | beta-1,2 | 1 |
| 59 | beta-2 | 476 |
| 60 | beta-2-adrenoceptor | 1 |
| 61 | beta-2-receptor | 1 |
| 62 | beta-3 | 19 |
| 63 | beta-adrenergic-receptor | 4 |
| 64 | beta-adrenoreceptor | 43 |
| 65 | beta-peptide | 5 |
| 66 | beta-protein | 4 |
| 67 | beta/proposed | 1 |
| 68 | beta1+2 | 5 |
| 69 | beta1-adrenoreceptor | 3 |
| 70 | beta1-receptor | 8 |
| 71 | beta2 | 135 |
| 72 | beta2-adrenoceptor | 44 |
| 73 | betareceptor | 1 |
| 74 | beta₂ | 5 |
| 75 | beta₂-adrenergic | 2 |
| 76 | bk-channel | 1 |
| 77 | bkca-channel | 2 |
| 78 | ca2+-channel | 2 |
| 79 | calcium-channel | 215 |
| 80 | calcium-channels | 2 |
| 81 | calcium-entry | 7 |
| 82 | cannabinoid1 | 1 |
| 83 | catechol-o-methyl-transferase | 3 |
| 84 | catechol-o-methyltransferase | 76 |
| 85 | cb-receptor | 1 |
| 86 | cb1-receptor | 3 |
| 87 | ccb-ras | 1 |
| 88 | cg-b | 3 |
| 89 | chlerodendrum | 1 |
| 90 | chromane | 1 |
| 91 | co-stimulation | 18 |
| 92 | codon39 | 1 |
| 93 | constitutive1 | 1 |
| 94 | cuts/10 | 1 |
| 95 | cyclo-oxygenase | 133 |
| 96 | cyclo-oxygenase-2 | 57 |
| 97 | cyclooxygenase | 443 |
| 98 | cyclooxygenase- | 4 |
| 99 | cyclooxygenase-2 | 433 |
| 100 | cycloxygenase | 6 |
| 101 | d-aspartate-receptor | 1 |
| 102 | desmethylprodine | 1 |
| 103 | dichloroaniline | 1 |
| 104 | diestradiol | 2 |
| 105 | diethylaminoethyl | 3 |
| 106 | dishevelled | 3 |
| 107 | diuretics/beta | 1 |
| 108 | diuretics/β | 1 |
| 109 | dl-threo-3-hydroxyaspartate | 1 |
| 110 | dl-threo-methylphenidate | 2 |
| 111 | doxycyclin | 4 |
| 112 | dreb2 | 3 |
| 113 | drugs-or | 1 |
| 114 | dualaction | 1 |
| 115 | elastase-alpha | 4 |
| 116 | electuary | 1 |
| 117 | erbb-family | 2 |
| 118 | estradiol/norgestrel | 1 |
| 119 | eta/etb | 3 |
| 120 | factory-made | 4 |
| 121 | fibrinolysin | 2 |
| 122 | gabarα1 | 1 |
| 123 | gauducheau | 2 |
| 124 | gi-coupled | 2 |
| 125 | glp-1-receptor | 1 |
| 126 | glyceryltrinitrate | 6 |
| 127 | gp2b/3a | 3 |
| 128 | gpiibiiia | 3 |
| 129 | gtn/24 | 1 |
| 130 | gα | 20 |
| 131 | ha3ar | 13 |
| 132 | hcn-specific | 1 |
| 133 | hemoximeter | 2 |
| 134 | hkv1.5 | 3 |
| 135 | hostility-in | 2 |
| 136 | ics+laba+long-acting | 1 |
| 137 | if-channel | 1 |
| 138 | immune-derived | 2 |
| 139 | inhibitors/angiotensin-receptor | 1 |
| 140 | inhibitors/receptor | 2 |
| 141 | jadera | 2 |
| 142 | kcnk | 1 |
| 143 | kcnk3/kcnk9/kcnk18 | 1 |
| 144 | l-channel | 1 |
| 145 | low-titre | 4 |
| 146 | m1/m4 | 1 |
| 147 | mbaa | 1 |
| 148 | medroxyprogesterone-acetate | 1 |
| 149 | meo-m-bdc | 4 |
| 150 | metylenedioxymethamphetamine | 1 |
| 151 | micro-1 | 1 |
| 152 | mineralocorticoid-receptor | 6 |
| 153 | mixed-action | 1 |
| 154 | mrna+ | 1 |
| 155 | mrna-expressing | 1 |
| 156 | multiple-pathway | 3 |
| 157 | munc-18b | 2 |
| 158 | muscarinic-receptor | 2 |
| 159 | m₃ | 2 |
| 160 | niacin/lrpt | 1 |
| 161 | nomac/e | 6 |
| 162 | non-alpha-2 | 1 |
| 163 | non-beta | 4 |
| 164 | non-mu | 1 |
| 165 | non-n-methyl-d-aspartate | 3 |
| 166 | non-substrate | 3 |
| 167 | nonmyxopapillary | 2 |
| 168 | nonproblematic | 1 |
| 169 | norethisterone-enanthate | 1 |
| 170 | ofprecipitated | 1 |
| 171 | oral-delivery-system | 1 |
| 172 | overexpression-transgenic | 1 |
| 173 | p-componen | 1 |
| 174 | p-component | 3 |
| 175 | p-jak | 6 |
| 176 | pan-selectin | 3 |
| 177 | pancreatic-g-protein-coupled | 1 |
| 178 | pca-administered | 1 |
| 179 | peripheral-expressing | 1 |
| 180 | pesticide-oligo | 3 |
| 181 | phophodiesterase-4-selective | 1 |
| 182 | phosphatidylinositol-3-kinase | 50 |
| 183 | phosphodiesterase-type-5 | 2 |
| 184 | pingchan | 1 |
| 185 | poly-4 | 1 |
| 186 | positively-charged | 4 |
| 187 | post-tnf | 1 |
| 188 | postneuromuscular | 1 |
| 189 | potassium-channel | 6 |
| 190 | pregnancy-specific-beta | 1 |
| 191 | psyllogel | 4 |
| 192 | ptmba | 3 |
| 193 | quinolone-fused | 1 |
| 194 | r-methamphetamine | 1 |
| 195 | receptor-alpha-chain | 1 |
| 196 | renin-angiotensin-aldosterone-system | 18 |
| 197 | renin-angiotensin-system | 15 |
| 198 | rfrp-3-immunoreactive | 4 |
| 199 | ribokinase | 2 |
| 200 | rotheca | 1 |
| 201 | rs3916874 | 1 |
| 202 | sbn | 2 |
| 203 | self-reduce | 1 |
| 204 | serotonin2 | 1 |
| 205 | serotonin2-receptor | 1 |
| 206 | short-echo | 2 |
| 207 | si/sio | 4 |
| 208 | single-pathway | 1 |
| 209 | slb-induced | 1 |
| 210 | sodium-channel | 7 |
| 211 | sp-receptor | 3 |
| 212 | spectrum-beta | 1 |
| 213 | sphingosine-1-phosphate | 20 |
| 214 | ss2 | 9 |
| 215 | tetraphenylethene | 3 |
| 216 | tgase | 3 |
| 217 | thc-containing | 1 |
| 218 | theophylline-beta | 1 |
| 219 | topoisomerase-i | 4 |
| 220 | trp-channel | 3 |
| 221 | univent | 4 |
| 222 | v-5 | 2 |
| 223 | vaccine.in | 1 |
| 224 | vaporrub | 1 |
| 225 | video-electroencephalography | 5 |
| 226 | wintry | 1 |
| 227 | wt/deletion | 1 |
| 228 | µ-agonistic | 1 |
| 229 | ß-2 | 1 |
| 230 | ß-receptor | 1 |
| 231 | ß2 | 1 |
| 232 | α-adrenoceptor | 7 |
| 233 | α/β-adrenoreceptor | 1 |
| 234 | α1-ars | 3 |
| 235 | α4β | 1 |
| 236 | β-1.3/1.6-d-glucan | 1 |
| 237 | β-2 | 25 |
| 238 | β-peptide | 7 |
| 239 | β-predominant | 1 |
| 240 | β-protein | 6 |
| 241 | β-receptor | 14 |
| 242 | β1-adrenoceptor | 7 |
| 243 | β1-adrenoreceptor | 3 |
| 244 | β1-receptor | 5 |
| 245 | β1-selective | 4 |
| 246 | β2 | 134 |
| 247 | β2-adrenoceptor | 16 |
| 248 | β2-adrenoreceptor | 6 |
| 249 | β25-35 | 1 |
| 250 | β₂ | 12 |
| 251 | β₂-adrenoceptor | 7 |
| 252 | μ-type | 1 |
| 253 | τhat | 1 |
| 1 | mrna+ | 1 |
| 2 | 5-arylidene-3- | 1 |
| 3 | cyclooxygenase- | 4 |
| 4 | =1,3-di- | 1 |
| 5 | cuts/10 | 1 |
| 6 | alfa-1 | 2 |
| 7 | alpha-1 | 105 |
| 8 | beta-1 | 72 |
| 9 | micro-1 | 1 |
| 10 | at-1 | 7 |
| 11 | 9831 | 1 |
| 12 | arg389arg-beta1 | 1 |
| 13 | cannabinoid1 | 1 |
| 14 | constitutive1 | 1 |
| 15 | gabarα1 | 1 |
| 16 | beta1+2 | 5 |
| 17 | beta-1,2 | 1 |
| 18 | alpha-2 | 81 |
| 19 | non-alpha-2 | 1 |
| 20 | beta-2 | 476 |
| 21 | cyclo-oxygenase-2 | 57 |
| 22 | cyclooxygenase-2 | 433 |
| 23 | at-2 | 3 |
| 24 | ß-2 | 1 |
| 25 | β-2 | 25 |
| 26 | 2,352 | 1 |
| 27 | alpha2 | 67 |
| 28 | beta2 | 135 |
| 29 | dreb2 | 3 |
| 30 | serotonin2 | 1 |
| 31 | ss2 | 9 |
| 32 | ß2 | 1 |
| 33 | β2 | 134 |
| 34 | beta-3 | 19 |
| 35 | 2,3-dihydroquinazolin-4 | 2 |
| 36 | poly-4 | 1 |
| 37 | gtn/24 | 1 |
| 38 | 21/164 | 2 |
| 39 | rs3916874 | 1 |
| 40 | m1/m4 | 1 |
| 41 | phosphodiesterase-type-5 | 2 |
| 42 | v-5 | 2 |
| 43 | hkv1.5 | 3 |
| 44 | β25-35 | 1 |
| 45 | 79.95 | 3 |
| 46 | 52466 | 3 |
| 47 | 241/576 | 1 |
| 48 | kcnk3/kcnk9/kcnk18 | 1 |
| 49 | 215.8-268.9 | 1 |
| 50 | 10×109 | 3 |
| 51 | codon39 | 1 |
| 52 | -592a | 1 |
| 53 | gp2b/3a | 3 |
| 54 | mbaa | 1 |
| 55 | ptmba | 3 |
| 56 | rotheca | 1 |
| 57 | =rotheca | 1 |
| 58 | elastase-alpha | 4 |
| 59 | gpiibiiia | 3 |
| 60 | jadera | 2 |
| 61 | beta | 7,730 |
| 62 | pregnancy-specific-beta | 1 |
| 63 | theophylline-beta | 1 |
| 64 | spectrum-beta | 1 |
| 65 | non-beta | 4 |
| 66 | anticholinergic/beta | 1 |
| 67 | diuretics/beta | 1 |
| 68 | cg-b | 3 |
| 69 | munc-18b | 2 |
| 70 | eta/etb | 3 |
| 71 | vaporrub | 1 |
| 72 | alpha-2c | 1 |
| 73 | meo-m-bdc | 4 |
| 74 | hcn-specific | 1 |
| 75 | alpha1-adrenergic | 19 |
| 76 | beta₂-adrenergic | 2 |
| 77 | overexpression-transgenic | 1 |
| 78 | nonproblematic | 1 |
| 79 | a-sympathetic | 1 |
| 80 | µ-agonistic | 1 |
| 81 | slb-induced | 1 |
| 82 | 1-blocker-induced | 1 |
| 83 | positively-charged | 4 |
| 84 | dishevelled | 3 |
| 85 | gi-coupled | 2 |
| 86 | pancreatic-g-protein-coupled | 1 |
| 87 | pca-administered | 1 |
| 88 | beta/proposed | 1 |
| 89 | quinolone-fused | 1 |
| 90 | antagonist-precipitated | 2 |
| 91 | ofprecipitated | 1 |
| 92 | immune-derived | 2 |
| 93 | 3.16-fold | 1 |
| 94 | nomac/e | 6 |
| 95 | self-reduce | 1 |
| 96 | factory-made | 4 |
| 97 | beta-peptide | 5 |
| 98 | β-peptide | 7 |
| 99 | 4,6-diamidino-2-phenylindole | 4 |
| 100 | chromane | 1 |
| 101 | tetraphenylethene | 3 |
| 102 | desmethylprodine | 1 |
| 103 | dichloroaniline | 1 |
| 104 | r-methamphetamine | 1 |
| 105 | metylenedioxymethamphetamine | 1 |
| 106 | angular-type | 2 |
| 107 | μ-type | 1 |
| 108 | low-titre | 4 |
| 109 | tgase | 3 |
| 110 | amidohydrolase | 5 |
| 111 | cyclo-oxygenase | 133 |
| 112 | cycloxygenase | 6 |
| 113 | cyclooxygenase | 443 |
| 114 | phosphatidylinositol-3-kinase | 50 |
| 115 | ribokinase | 2 |
| 116 | catechol-o-methyl-transferase | 3 |
| 117 | catechol-o-methyltransferase | 76 |
| 118 | antagonists/inverse | 1 |
| 119 | benzene-1,3,5-tri-carboxyl-ate | 2 |
| 120 | dl-threo-methylphenidate | 2 |
| 121 | sphingosine-1-phosphate | 20 |
| 122 | norethisterone-enanthate | 1 |
| 123 | glyceryltrinitrate | 6 |
| 124 | non-substrate | 3 |
| 125 | medroxyprogesterone-acetate | 1 |
| 126 | non-n-methyl-d-aspartate | 3 |
| 127 | dl-threo-3-hydroxyaspartate | 1 |
| 128 | rfrp-3-immunoreactive | 4 |
| 129 | β1-selective | 4 |
| 130 | phophodiesterase-4-selective | 1 |
| 131 | benzodiazepine-positive | 1 |
| 132 | post-tnf | 1 |
| 133 | thc-containing | 1 |
| 134 | mrna-expressing | 1 |
| 135 | peripheral-expressing | 1 |
| 136 | ics+laba+long-acting | 1 |
| 137 | 1/th | 1 |
| 138 | topoisomerase-i | 4 |
| 139 | p-jak | 6 |
| 140 | kcnk | 1 |
| 141 | a-ldl | 2 |
| 142 | psyllogel | 4 |
| 143 | allel | 1 |
| 144 | ca2+-channel | 2 |
| 145 | atp-k+-channel | 1 |
| 146 | bkca-channel | 2 |
| 147 | if-channel | 1 |
| 148 | bk-channel | 1 |
| 149 | l-channel | 1 |
| 150 | calcium-channel | 215 |
| 151 | arb/calcium-channel | 1 |
| 152 | sodium-channel | 7 |
| 153 | potassium-channel | 6 |
| 154 | trp-channel | 3 |
| 155 | estradiol/norgestrel | 1 |
| 156 | diestradiol | 2 |
| 157 | diethylaminoethyl | 3 |
| 158 | renin-angiotensin-aldosterone-system | 18 |
| 159 | renin-angiotensin-system | 15 |
| 160 | oral-delivery-system | 1 |
| 161 | chlerodendrum | 1 |
| 162 | β-1.3/1.6-d-glucan | 1 |
| 163 | pingchan | 1 |
| 164 | sbn | 2 |
| 165 | p-componen | 1 |
| 166 | hostility-in | 2 |
| 167 | vaccine.in | 1 |
| 168 | receptor-alpha-chain | 1 |
| 169 | beta-protein | 4 |
| 170 | β-protein | 6 |
| 171 | doxycyclin | 4 |
| 172 | 3-hydroxyquinolin | 2 |
| 173 | fibrinolysin | 2 |
| 174 | pan-selectin | 3 |
| 175 | co-stimulation | 18 |
| 176 | mixed-action | 1 |
| 177 | dualaction | 1 |
| 178 | wt/deletion | 1 |
| 179 | pesticide-oligo | 3 |
| 180 | short-echo | 2 |
| 181 | si/sio | 4 |
| 182 | atp-grasp | 2 |
| 183 | atv+r | 9 |
| 184 | at-1r | 3 |
| 185 | ha3ar | 13 |
| 186 | postneuromuscular | 1 |
| 187 | hemoximeter | 2 |
| 188 | amkr | 2 |
| 189 | drugs-or | 1 |
| 190 | glp-1-receptor | 1 |
| 191 | alpha1-receptor | 5 |
| 192 | beta1-receptor | 8 |
| 193 | cb1-receptor | 3 |
| 194 | at1-receptor | 48 |
| 195 | β1-receptor | 5 |
| 196 | beta-2-receptor | 1 |
| 197 | serotonin2-receptor | 1 |
| 198 | alpha-receptor | 18 |
| 199 | 5-alpha-receptor | 1 |
| 200 | cb-receptor | 1 |
| 201 | adrenergic-receptor | 1 |
| 202 | beta-adrenergic-receptor | 4 |
| 203 | muscarinic-receptor | 2 |
| 204 | mineralocorticoid-receptor | 6 |
| 205 | d-aspartate-receptor | 1 |
| 206 | angiotensin-ii-receptor | 4 |
| 207 | angiotensin-receptor | 179 |
| 208 | inhibitors/angiotensin-receptor | 1 |
| 209 | sp-receptor | 3 |
| 210 | ß-receptor | 1 |
| 211 | β-receptor | 14 |
| 212 | inhibitors/receptor | 2 |
| 213 | betareceptor | 1 |
| 214 | alpha1-adrenoreceptor | 1 |
| 215 | beta1-adrenoreceptor | 3 |
| 216 | β1-adrenoreceptor | 3 |
| 217 | β2-adrenoreceptor | 6 |
| 218 | beta-adrenoreceptor | 43 |
| 219 | α/β-adrenoreceptor | 1 |
| 220 | β1-adrenoceptor | 7 |
| 221 | beta-2-adrenoceptor | 1 |
| 222 | beta2-adrenoceptor | 44 |
| 223 | β2-adrenoceptor | 16 |
| 224 | β₂-adrenoceptor | 7 |
| 225 | α-adrenoceptor | 7 |
| 226 | ccb-ras | 1 |
| 227 | alk5/smads | 2 |
| 228 | calcium-channels | 2 |
| 229 | -cycloalkyls | 1 |
| 230 | α1-ars | 3 |
| 231 | τhat | 1 |
| 232 | arndt | 4 |
| 233 | β-predominant | 1 |
| 234 | p-component | 3 |
| 235 | univent | 4 |
| 236 | niacin/lrpt | 1 |
| 237 | gauducheau | 2 |
| 238 | non-mu | 1 |
| 239 | single-pathway | 1 |
| 240 | multiple-pathway | 3 |
| 241 | video-electroencephalography | 5 |
| 242 | erbb-family | 2 |
| 243 | nonmyxopapillary | 2 |
| 244 | electuary | 1 |
| 245 | calcium-entry | 7 |
| 246 | wintry | 1 |
| 247 | beta₂ | 5 |
| 248 | β₂ | 12 |
| 249 | m₃ | 2 |
| 250 | gα | 20 |
| 251 | anti-β | 2 |
| 252 | diuretics/β | 1 |
| 253 | α4β | 1 |